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Response from the Authors  
In response 
The authors are satisfied that their original responses to the prior Manuscript Clarification 
address the issues raised here. 
 
Lowery et al. (6) reported, in contrast to an often‐observed heterogeneity in training‐induced 
hypertrophy, remarkably consistent between‐group changes in muscle mass to find statistical 
significance between an HMB‐FA+AP supplemented (n=8) versus a placebo (n=9) groups. The 
difference divergence between the supplemented and placebo groups occurred despite optimal 
training and optimal nutritional support. We note that HMB has been shown to result in a trivial 
training‐induced adaptive advantage (8) and that the gain in lean body mass was in previously 
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resistance‐trained subjects who would have had less propensity to gain lean body mass (7). For 
absolute clarity, could the authors please present the absolute body weight and body composition 
(lean body mass and fat mass) as opposed to % change data? We believe this would be helpful 
for readers. There are data for calcium HMB showing improved muscle protein turnover (9). We 
are unaware of any similar data for FA‐HMB despite greater bioavailability and uptake (into 
what tissue is unknown) (3). Do the authors know of any data showing that HMB‐FA affects 
human muscle protein turnover (9)? We note that leucine had the same anabolic effects as 
calcium‐HMB (9) and that dietary protein can exert a positive effect on gains in muscle mass 
with resistance training (1). The placebo group, recipients of optimal protein/leucine intake, did 
not appear to respond at all to the overreaching phase. Can the authors speculate why? Lowery et 
al (6) supplemented with ATP, which has undetectable bioavailability (2). Wilson et al. (10), 
reported that ATP (400mg/d) resulted in a positive effect on muscle mass, strength, and power 
gains. The authors’ state (4) that a previously reported increase in post‐exercise blood flow 
induced by the ATP (5) in the supplemented group could be responsible. The magnitude of that 
flow increase was only about 100‐150 ml/min, was not consistently observed across weeks of 
supplementation, and lasted no more than 3‐6min post‐exercise (5). How do the authors think a 
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small, inconsistent, and short‐lasting increase in blood flow could affect performance? In the 
response to Hyde et al (4), Lowery et al. (6) stated that they selected “…a responsive population 
who possess a quantity of lean mass indicative of previous responses to resistance training…” 
What was the screening process to pick the participants? The authors state their subjects had 
muscle “…an order of magnitude [an order of magnitude is defined as 10‐times greater, so this 
cannot be the case] higher than average lean mass…” Could the authors please state the exact 
criteria for inclusion as a participant? It would be useful for the authors to describe how many 
participants were recruited and screened, the final number entered into the study and the number 
of dropouts. Were participants randomized to treatment and placebo groups, pair matched based 
on body mass, lean body mass, strength or another variable? 
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